moxisylyte has been researched along with scopolamine hydrobromide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bard, B; Carrupt, PA; Martel, S | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Fawke, L | 1 |
1 review(s) available for moxisylyte and scopolamine hydrobromide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for moxisylyte and scopolamine hydrobromide
| Article | Year |
|---|---|
Lipophilicity of basic drugs measured by hydrophilic interaction chromatography.
Topics: Chemistry, Pharmaceutical; Chromatography; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Pharmaceutical Preparations; Solubility; Technology, Pharmaceutical | 2009 |
Thymoxamine on the guinea-pig vas deferens: an effect unrelated to alpha-receptor blockade.
Topics: Acetylcholine; Adrenergic alpha-Antagonists; Animals; Aspirin; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Electric Stimulation; Guinea Pigs; Hypogastric Plexus; In Vitro Techniques; Male; Moxisylyte; Muscles; Phentolamine; Phenylephrine; Physostigmine; Propranolol; Scopolamine; Vas Deferens | 1973 |